Production (Stage)
Milestone Pharmaceuticals Inc.
MIST
$1.73
-$0.01-0.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -100.00% | -100.00% | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -100.00% | -100.00% | -100.00% |
| SG&A Expenses | 15.22% | -10.63% | -5.77% | 11.76% | 22.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.00% | -32.20% | -33.56% | -26.12% | -16.43% |
| Operating Income | 7.00% | 31.09% | 28.67% | 18.82% | 8.22% |
| Income Before Tax | 5.74% | 30.44% | 27.82% | 17.57% | 7.15% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.74% | 30.44% | 27.82% | 17.57% | 7.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.74% | 30.44% | 27.82% | 17.57% | 7.15% |
| EBIT | 7.00% | 31.09% | 28.67% | 18.82% | 8.22% |
| EBITDA | 7.01% | 31.16% | 28.74% | 18.88% | 8.27% |
| EPS Basic | 37.15% | 51.28% | 41.61% | 26.09% | 10.50% |
| Normalized Basic EPS | 37.14% | 51.28% | 41.61% | 26.08% | 10.49% |
| EPS Diluted | 37.15% | 51.28% | 41.61% | 26.09% | 10.50% |
| Normalized Diluted EPS | 37.14% | 51.28% | 41.61% | 26.08% | 10.49% |
| Average Basic Shares Outstanding | 47.89% | 44.79% | 31.50% | 18.29% | 5.12% |
| Average Diluted Shares Outstanding | 47.89% | 44.79% | 31.50% | 18.29% | 5.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |